Trials / Completed
CompletedNCT03618225
Duloxetine Role in Reducing Opioid Consumption After Thoracotomy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
A total of 60 patients scheduled for thoracotomy with the aim of excision of pleural or lung cancer, will be randomized by the use of a computer-generated table of random numbers to receive duloxetine 60 mg orally 2 hours before the surgical procedure and at 24 hours after the surgical procedure or a placebo pill following the same time schedule.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oral Duloxetine 60mg | duloxetine 60 mg orally 2 hours before the surgical procedure and at 24 hours after the surgical procedure |
| DRUG | placebo pill | placebo pill orally 2 hours before the surgical procedure and at 24 hours after the surgical procedure |
Timeline
- Start date
- 2018-08-15
- Primary completion
- 2020-01-31
- Completion
- 2020-01-31
- First posted
- 2018-08-07
- Last updated
- 2021-10-14
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03618225. Inclusion in this directory is not an endorsement.